Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions
- PMID: 17460457
- DOI: 10.1097/01.pas.0000213417.00386.74
Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions
Abstract
We describe the histologic variants of papillary and follicular carcinomas associated with 109 spindle and giant cell carcinomas (SGCC) of the thyroid and determine the incidence of rhabdoid and thyroglobulin inclusions in these tumors. In addition, we searched for rhabdoid and thyroglobulin inclusions in 120 papillary carcinomas (PC) (all 15 variants included), 23 differentiated follicular carcinomas (DFC), (6 with insular pattern), 6 poorly differentiated follicular carcinomas (PDFC) and 34 follicular adenomas (FA). The following differentiated thyroid carcinomas coexisted with SGCC: 51 (46.8%) PC, (34 conventional type, 14 tall cell variant and 3 follicular variant), 6 (5.5%) DFC, 1 follicular carcinoma with insular pattern (0.9%), and 3 oncocytic carcinomas (2.8%). Eleven SGCC (10%) and 2 (33%) PDFC showed rhabdoid features, but lacked thyroglobulin inclusions. Thyroglobulin inclusions were found in 10 FA (29%), 8 (17%) follicular variants of PC and in 7 (30.4%) DFC. There were no rhabdoid inclusions in any of these differentiated thyroid tumors. Our findings support the hypothesis that most SGCC result from dedifferentiation or anaplastic transformation although the mechanisms that underlie this transformation remain unknown. The finding that only 1 (0.9%) SGCC was associated with follicular carcinoma with insular pattern contradicts the opinion that this tumor occupies an intermediate position between differentiated and anaplastic carcinomas. Rhabdoid features are markers of PDFC and SGCC while thyroglobulin inclusions are markers of FA and differentiated thyroid carcinomas with follicular phenotype.
Similar articles
-
Poorly differentiated follicular thyroid carcinoma with rhabdoid phenotype: a clinicopathologic, immunohistochemical and electron microscopic study of two cases.Mod Pathol. 2001 Feb;14(2):98-104. doi: 10.1038/modpathol.3880263. Mod Pathol. 2001. PMID: 11235911
-
Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.Hum Pathol. 2000 Sep;31(9):1139-45. doi: 10.1053/hupa.2000.16667. Hum Pathol. 2000. PMID: 11014583
-
OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.J Med Assoc Thai. 2005 Nov;88 Suppl 3:S281-9. J Med Assoc Thai. 2005. PMID: 16858970 Review.
-
Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.Cancer. 2004 Mar 1;100(5):950-7. doi: 10.1002/cncr.20087. Cancer. 2004. PMID: 14983490
-
Papillary thyroid carcinoma variants.Head Neck Pathol. 2011 Mar;5(1):51-6. doi: 10.1007/s12105-010-0236-9. Epub 2011 Jan 8. Head Neck Pathol. 2011. PMID: 21221869 Free PMC article. Review.
Cited by
-
WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.J Med Life. 2024 Jan;17(1):15-23. doi: 10.25122/jml-2023-0270. J Med Life. 2024. PMID: 38737660 Free PMC article.
-
Overview of the 2022 WHO Classification of Thyroid Neoplasms.Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14. Endocr Pathol. 2022. PMID: 35288841 Review.
-
Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.Int J Clin Exp Pathol. 2010 Oct 1;3(8):755-62. Int J Clin Exp Pathol. 2010. PMID: 21151388 Free PMC article.
-
Anaplastic thyroid carcinoma with rhabdomyoblastic differentiation: a case report with a good clinical outcome.Endocr Pathol. 2008 Spring;19(1):62-5. doi: 10.1007/s12022-008-9017-3. Endocr Pathol. 2008. PMID: 18330722
-
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Nat Rev Endocrinol. 2017 Nov;13(11):644-660. doi: 10.1038/nrendo.2017.76. Epub 2017 Jul 14. Nat Rev Endocrinol. 2017. PMID: 28707679 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical